Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients

Schizophr Res. 2008 Aug;103(1-3):319-21. doi: 10.1016/j.schres.2008.04.030. Epub 2008 Jun 16.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Basal Ganglia / drug effects*
  • Basal Ganglia / pathology
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / pathology
  • Dibenzothiazepines / adverse effects
  • Dibenzothiazepines / therapeutic use*
  • Female
  • Humans
  • Image Processing, Computer-Assisted*
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Quetiapine Fumarate
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*

Substances

  • Dibenzothiazepines
  • Quetiapine Fumarate